INC Research/inVentiv now Syneos Health

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/manaemedia)
(Image: iStock/manaemedia)

Related tags: Management occupations

INC Research/inVentiv Health is starting the new year with a rebrand after merging to create one of the largest biopharmaceutical outsourcing providers in 2017.

The company​, with a combined staff of more than 21,000 employees across more than 60 counties, will now be known as Syneos Health, Inc., effective January 4, 2018.

Syneos Health common shares will trade on the Nasdaq Global Select Market under the new ticker symbol “SYNH” by January 9, 2018.

"Since close, we’ve quickly assembled an Integrated Solutions Group, bringing together seasoned industry product strategists with regulatory, clinical, commercial and real world expertise​," Alistair Macdonald, CEO of Syneos Health told

"This group is working with customers across the small to mid to large continuum to determine the right mix of clinical and commercial capabilities to produce a higher likelihood of launch success,​” he added. 

Also this week, the company announced that Greg Rush is stepping down as chief financial officer (CFO) to pursue a different opportunity. The company has initiated the search for a replacement.

The current executive vice president and CFO of the company’s commercial solutions business will be appointed as interim CFO at the end of April if a replacement has not been found, according to the company.

Related news

Show more

Related products

show more


Lyophilization Scale-Up and Tech Transfer

Baxter BioPharma Solutions | 12-Mar-2018 | Technical / White Paper

There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation...

How will Brexit affect the Pharmaceutical Industry?

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Leveraging Best Practices in Primary Packaging

Leveraging Best Practices in Primary Packaging

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

When planning a clinical trial, overlooking the importance of primary packaging can be a mistake. From stability concerns to labeling to patient compliance...

VDS groß

Meet the challenges of complex injectables

Vetter Pharma International GmbH | 07-Nov-2017 | Technical / White Paper

In the time it takes from the exciting discovery phase to the rigorous demands of a commercial launch, unexpected scientific and technical challenges can...

Related suppliers